Stock Updates

How has Fresenius Medical Care AG & Co. KGAA:(NYSE:FMS) performed recently?

Fresenius Medical Care AG & Co. KGAA (NYSE: FMS) is a large market cap stock with a market cap of 27362.34. It is in the Specialized Health Services industry and sector Healthcare, with a current P/E of 25.63, a forward P/E of 19.1 and EPS of 1.72. At a stock price of 43.7 (-0.70%) it has a dividend yield of 1.02%.

EPS growth for the last five years have been 15.90%, more recently this last year it has grown by -2.00%. The next year growth is going to be about 13.55% and more long-term 9.60% after five years. EPS growth quarter over quarter is 8.50%. Sales growth for the past five years have been 7.20% and sales growth quarter over quarter is 6.20%.

For performance, Fresenius Medical Care AG & Co. KGAA the past week has seen a gain of 0.25%. For the last month performance for Fresenius Medical Care AG & Co. KGAA is 7.74%. While the last quarter is -1.22% and half year, 13.02%. Finally for the year, performance is 1.79%.

The 52-week high for Fresenius Medical Care AG & Co. KGAA, is at -3.71%, and for the 52-week low it comes to a value of 19.67%. The 20-day simple moving average is 2.64% and 3.43% for the 200-day simple moving average.

Volatility for the week is at 0.83%, and for the month it is 1.19%. Fresenius Medical Care AG & Co. KGAA, has a target price of 47.9.

In terms of debt, long term debt/equity is 0.77, and for total debt/equity Fresenius Medical Care AG & Co. KGAA has 0.88. The gross margin is 32.20%, while operating margin is 13.90%, the profit margin is 6.20%. The current ratio is 1.6 and the quick ratio is 1.3.

Insider ownership is at 35.70%, with instituitional ownership at 2.30%. Fresenius Medical Care AG & Co. KGAA has a payout ratio of 25.30%. With the total shares outstanding coming to 621.73. The shares float is 615.34, with the float short at 0.15%, with short ratio coming to 6.53.

In terms of returns, the return on assets see Fresenius Medical Care AG & Co. KGAA, get 4.10%, with its returns on investment at 9.10%. Return on equity is 10.70%. So will the investors see the target price of 47.9, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 

About the author

Tony Dabbs

Leave a Comment